Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children

Clinical and Experimental Allergy

Volumn 42, Issue 8, 2012, Pages 1197-1205

  Thyagarajan, A ^a   Jones, S M ^b   Calatroni, A ^c   Pons, L ^a   Kulis, M ^a   Woo, C S ^d   Kamalakannan, M ^d   Vickery, B P ^a   Scurlock, A M ^b   Wesley Burks, A ^a   Shreffler, W G ^d,e  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c Rho Federal Systems Division Inc   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Basophil anergy; CD203c; CD63; Desensitization; Human basophils; Oral immunotherapy; Peanut allergy

Indexed keywords

CD63 ANTIGEN; FOOD ALLERGEN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 3; PLACEBO;

ARTICLE; BASOPHIL; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EFFECTOR CELL; EGG ALLERGY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; ORAL IMMUNOTHERAPY; PEANUT; PEANUT ALLERGY; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; UPREGULATION;

ADMINISTRATION, ORAL; ALLERGENS; ANTIGENS, CD63; ARACHIS HYPOGAEA; BASOPHILS; CHILD; CHILD, PRESCHOOL; DESENSITIZATION, IMMUNOLOGIC; HUMANS; IMMUNE TOLERANCE; PEANUT HYPERSENSITIVITY; PHOSPHORIC DIESTER HYDROLASES; PYROPHOSPHATASES; RECEPTORS, IGE; SIGNAL TRANSDUCTION;

EID: 84864001792     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2012.04028.x     Document Type: Article

References (46)

1. Ben-Shoshan M, Kagan RS, Alizadehfar R et al. Is the prevalence of peanut allergy increasing? A 5-year follow-up study in children in Montreal. J Allergy Clin Immunol 2009; 123:783-8.
2. Mullins RJ, Dear KBG, Tang MLK. Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007. J Allergy Clin Immunol 2009; 123:689-93.
3. Sicherer SH, Muñoz-Furlong A, Godbold JH, Sampson HA. US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J Allergy Clin Immunol 2010; 125:1322-6.
4. Sicherer SH, Sampson HA. Food allergy: recent advances in pathophysiology and treatment. Annu Rev Med 2009; 60:261-77.
5. Clark AT, Ewan PW. Good prognosis, clinical features, and circumstances of peanut and tree nut reactions in children treated by a specialist allergy center. J Allergy Clin Immunol 2008; 122:286-9.
6. Bock SA, Muñoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001; 107:191-3.
7. Järvinen KM, Amalanayagam S, Shreffler WG et al. Epinephrine treatment is infrequent and biphasic reactions are rare in food-induced reactions during oral food challenges in children. J Allergy Clin Immunol 2009; 124:1267-72.
8. Chafen JJS, Newberry SJ, Riedl MA et al. Diagnosing and managing common food allergies: a systematic review. JAMA 2010; 303:1848-56.
9. Gibbs BF. Human basophils as effectors and immunomodulators of allergic inflammation and innate immunity. Clin Exper Med 2005; 5:43-9.
10. Schroeder JT, MacGlashan DW, Lichtenstein LM. Human basophils: mediator release and cytokine production. Adv Immunol 2001; 77:93-122.
11. Denzel A, Maus UA, Gomez MR et al. Basophils enhance immunological memory responses. Nat Immunol 2008; 9:733-42.
12. Karasuyama H, Mukai K, Tsujimura Y, Obata K. Newly discovered roles for basophils: a neglected minority gains new respect. Nat Rev Immunol 2009; 9:9-13.
13. Kim S, Shen T, Min B. Basophils can directly present or cross-present antigen to CD8 lymphocytes and alter CD8 T cell differentiation into IL-10-producing phenotypes. J Immunol 2009; 183:3033-9.
14. Sokol CL, Chu N, Yu S, Nish SA, Laufer TM, Medzhitov R. Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nat Immunol 2009; 10:713-20.
15. Eckman JA, Sterba PM, Kelly D et al. Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge. J Allergy Clin Immunol 2010; 125:889-895.
16. Sampson HA, Broadbent KR, Bernhisel-Broadbent J. Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity. N Engl J Med 1989; 321:228-32.
17. Sampson HA, Jolie PL. Increased plasma histamine concentrations after food challenges in children with atopic dermatitis. N Engl J Med 1984; 311:372-6.
18. Hennersdorf F, Florian S, Jakob A et al. Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns in time kinetics of IgE-dependent upregulation. Cell Res 2005; 15:325-35.
19. Dvorak AM. Ultrastructural studies of human basophils and mast cells. J Histochem Cytochem 2005; 53:1043-70.
20. Knol EF, Mul FP, Jansen H, Calafat J, Roos D. Monitoring human basophil activation via CD63 monoclonal antibody 435. J Allergy Clin Immunol 1991; 88:328-38.
21. Bühring HJ, Seiffert M, Giesert C et al. The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/phosphodiesterase 3. Blood 2001; 97:3303-5.
22. MacGlashan D. Expression of CD203c and CD63 in human basophils: relationship to differential regulation of piecemeal and anaphylactic degranulation processes. Clin Exp Allergy 2010; 40:1365-77.
23. Falcone FH, Telford G, Hooi D et al. Antigen-driven basophil activation is indicative of early Necator americanus infection in IgE-seronegative patients. J Allergy Clin Immunol 2009; 124:1343-50.
24. Gober LM, Eckman JA, Sterba PM et al. Expression of activation markers on basophils in a controlled model of anaphylaxis. J Allergy Clin Immunol 2007; 119:1181-8.
25. Lourenço FD, Azor MH, Santos JC et al. Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus. Br J Dermatol 2008; 158:979-86.
26. Ono E, Taniguchi M, Higashi N et al. CD203c expression on human basophils is associated with asthma exacerbation. J Allergy Clin Immunol 2010; 125:483-489.
27. Wanich N, Nowak-Wegrzyn A, Sampson HA, Shreffler WG. Allergen-specific basophil suppression associated with clinical tolerance in patients with milk allergy. J Allergy Clin Immunol 2009; 123:789-94.
28. Blumchen K, Ulbricht H, Staden U et al. Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol 2010; 126:83-91.e1
29. Jones SM, Pons L, Roberts JL et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 2009; 124:292-300, 300.e1-97.
30. Varshney P, Jones SM, Scurlock AM et al. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol 2011; 127:654-60.
31. MacGlashan DW, Vilariño N. Nonspecific desensitization, functional memory, and the characteristics of SHIP phosphorylation following IgE-mediated stimulation of human basophils. J Immunol 2006; 177:1040-51.
32. Pinheiro J, Bates DM. Mixed-effects models in S and S-Plus. In: Chambers J, Eddy W, eds. Statistics and computing. New York: Springer Verlag, 2000.
33. Ritz C, Streibig JC. Bioassay analysis using R. J Stat Softw 2005; 12:1-22.
34. R Development Core Team. R: A language and environment for statistical computing. ISBN. 2011. 3-900051-07-0.
35. Kepley CL, Cambier JC, Morel PA et al. Negative regulation of FcepsilonRI signaling by FcgammaRII costimulation in human blood basophils. J Allergy Clin Immunol 2000; 106:337-48.
36. Scadding GW, Shamji MH, Jacobson MR et al. Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells. Clin Exp Allergy 2010; 40:598-606.
37. Sancho-Serra MDC, Simarro M, Castells M. Rapid IgE desensitization is antigen specific and impairs early and late mast cell responses targeting FcεRI internalization. Eur J Immunol 2011;41:1004-13.
38. Kepley CL. Antigen-induced reduction in mast cell and basophil functional responses due to reduced Syk protein levels. Int Arch Allergy Immunol 2005; 138:29-39.
39. Hauswirth AW, Sonneck K, Florian S et al. Interleukin-3 promotes the expression of E-NPP3/CD203C on human blood basophils in healthy subjects and in patients with birch pollen allergy. Int J Immunopathol Pharmacol 2007; 20:267-78.
40. MacGlashan D, Honigberg L, Smith A, Buggy J, Schroeder JT. Inhibition of IgE-mediated secretion from human basophils with a highly selective Bruton's tyrosine kinase, Btk, inhibitor. Int Immunopharmacol 2011; 11:475-9.
41. Hida S, Yamasaki S, Sakamoto Y et al. Fc receptor gamma-chain, a constitutive component of the IL-3 receptor, is required for IL-3-induced IL-4 production in basophils. Nat Immunol 2009; 10:214-22.
42. Vilariño N, Miura K, MacGlashan DW. Acute IL-3 priming up-regulates the stimulus-induced Raf-1-Mek-Erk cascade independently of IL-3-induced activation of Erk. J Immunol 2005; 175:3006-14.
43. Lyngholm JM, Nielsen HV, Holm M, Schiøtz PO, Johnsen AH. Calreticulin is an interleukin-3-sensitive calcium-binding protein in human basophil leukocytes. Allergy 2001; 56:21-8.
44. Charles N, Hardwick D, Daugas E, Illei GG, Rivera J. Basophils and the T helper 2 environment can promote the development of lupus nephritis. Nat Med 2010; 16:701-7.
45. Hammad H, Plantinga M, Deswarte K et al. Inflammatory dendritic cells-not basophils-are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen. J Exp Med 2010; 207:2097-111.
46. Tang H, Cao W, Kasturi SP et al. The T helper type 2 response to cysteine proteases requires dendritic cell-basophil cooperation via ROS-mediated signaling. Nat Immunol 2010; 11:608-17.